In Washington Post, Health Care Partner Comments on State Legislation Targeting Drug Pricing Middleman

In The News
May 22, 2018
Thomas N. Bulleit

A May 21 article in The Washington Post’s Health 202 column on prescription drug pricing includes remarks from health care partner Tom Bulleit (Washington, D.C.), describing several different strategies that state legislatures have been taking to provide more regulation of pharmacy benefit managers, key “middlemen” in the drug supply chain that President Trump has stated his administration plans to make less “rich” as part of its 4-point plan to reduce prescription drug prices.


Thomas N. Bulleit
Thomas N. Bulleit
Retired Partner